Accelerating Biomedical Innovation Act

S 1441, the Accelerating Biomedical Innovation Act, establishes a new Center for Biomedical Innovation and Development to accelerate the development of medical countermeasures like vaccines, drugs, and devices. The Secretary of Health and Human Services must select at least three higher education institutions meeting specific criteria (including advanced manufacturing expertise and facilities) to form this Center within one year of the bill's enactment. The Center will provide direct support to developers through pilot manufacturing, technical assistance, regulatory help, and coordination with manufacturers for products using novel technology to address unmet health needs. This program directly affects eligible universities selected for the consortium and biomedical developers referred by BARDA (Biomedical Advanced Research and Development Agency).